New Jersey Launches Investigation of Amgen’s Enbrel Marketing Practices
This article was originally published in The Pink Sheet Daily
State attorney general subpoenas Amgen in the wake of lawsuits filed by former sales reps that allege off-label marketing.
You may also be interested in...
Purdue pleads guilty to illegally promoting and selling the painkiller, ending an investigation by the U.S. Attorney’s Office in Virginia.
Justice Ginsburg wrote two decisions in pharmaceutical related-cases over the past decade, joined the majority in opinions on the scope of patents, and dissented in decisions giving protection to generic manufacturers and speech of pharmaceutical companies. Her death could impact the outcome of cases challenging the Affordable Care Act.
Neither has announced a firm timeline, and the difference between Pfizer's 'October' and Moderna's 'November' could be mere hours or a few weeks, but Pfizer, by dint of luck or experience, is now in a position to offer the more optimistic projection on when it will seek an EUA. Both firms release their Phase III trial protocols, which seem in line with US FDA guidance.